Thrombocytopenia after treatment for nasopharyngeal carcinoma : acomparison of radiotherapy and chemoradiotherapy
Abstract
Nasopharyngeal carcinoma (NPC) arises from the nasopharyngeal epithelium. Radiotherapy is the mainstay for locoregional NPC, while concurrent chemoradiotherapy is standard for advanced locoregional disease. Both modalities can affect hematopoiesis and alter platelet counts, but comparative data on treatment-related thrombocytopenia are limited. We retrospectively reviewed medical records of 66 NPC patients treated at Dr Kariadi General Hospital between 2016 and 2023. Collected variables included age, sex, histopathological type, stage, and platelet counts before and after therapy. Descriptive statistics summarised patient characteristics. Paired T-tests were used to evaluate within-patient changes in platelet count pre- versus post-treatment. The association between treatment modality (radiotherapy vs chemoradiotherapy) and occurrence of thrombocytopenia was assessed using the Chi-Square test. Most patients were male (75.8%) and ≥40 years old (75.8%). WHO type 3 histology comprised 83.3% of cases; stage IVA was the most common stage (42.4%). Mean platelet counts decreased from 364.18 × 103/μL to 248.76 × 103/μL after radiotherapy, and from 390.18 × 103/μL to 209.24 × 103/μL after chemoradiotherapy. Thrombocytopenia occurred in 5/33 patients (15.2%) receiving radiotherapy and 13/33 patients (39.4%) receiving chemoradiotherapy. In this cohort, NPC predominantly affected males ≥40 years with WHO type 3 histology and stage IVA disease. Both radiotherapy and chemoradiotherapy were associated with reductions in platelet count, with a higher observed incidence of thrombocytopenia following chemoradiotherapy. Prospective studies with larger samples are warranted to confirm these findings and to identify risk factors for clinically significant thrombocytopenia.
Downloads
License
© 2026 Author(s). Published by Sains Medika: Jurnal Kedokteran dan Kesehatan. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Adham, M., Kurniawan, A. N., Muhtadi, A. I., Roezin, A., Hermani, B., Gondhowiardjo, S., Tan, I. B., & Middeldorp, J. M. (2012). Nasopharyngeal carcinoma in Indonesia: Epidemiology, incidence, signs, and symptoms at presentation. Chinese Journal of Cancer, 31(4): 185–196. https://doi.org/10.5732/cjc.011.10328
Al-Azri, M. H. (2016). Delay in cancer diagnosis: Causes and possible solutions. Oman Medical Journal, 31(5): 325–326. https://doi.org/10.5001/omj.2016.65
Apreza, T.R., & Gondhowiardjo, S. A. (2021). The effect of bone radiation on hematopoiesis: A literature review. Radioterapi & Onkologi Indonesia, 12(2): 62-69. https://garuda.kemdiktisaintek.go.id/documents/detail/2439112
Asnir, R. A., Yudhistira, A., & Friliandita, N. (2020). Profile of nasopharyngeal cancer patients in Otorhinolaryngology - HNS Department Haji Adam Malik General Hospital Medan during 2014 - 2016. International Journal of Nasopharyngeal Carcinoma, 2(3): 79–81. https://www.academia.edu/download/111287394/352930486.pdf
Audina, N. T., Yusmawan, W., Naftali, Z., & Suprihati, S. (2019). Perbandingan kejadian leukopenia dan trombositopenia pada penderita karsinoma nasofaring yang mendapatkan kemoterapi paclitaxel-cisplatin dan cisplatin-5-fluorourasil (5-FU). Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal), 8(4): 1187-1196. https://doi.org/10.14710/dmj.v8i4.25355
Bagby, G. (2004). Leucopenia and leucocytosis. In Cecil Textbook of Medicine (22nd ed., pp. 9–98). Philadelphia, PA: Saunders.
Barabas, K., Milner, R., Lurie, D., & Adin, C. (2008). Cisplatin: a review of toxicities and therapeutic applications. Veterinary and Comparative Oncology, 6(1): 1–18. https://doi.org/10.1111/j.1476-5829.2007.00142.x
Chang, E. T., Ye, W., Zeng, Y. X., & Adami, H. O. (2021). The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 30(6): 1035–1047. https://doi.org/10.1158/1055-9965.EPI-20-1702
Fauzan, A., Susilawati, S., & Larasati, V. (2022). The association between clinical characteristics and histopathology of nasopharyngeal carcinoma at Dr. Mohammad Hoesin General Hospital, in 2019-2020. Biomedical Journal of Indonesia, 8(1): 13–19. https://doi.org/10.32539/BJI.v8i1.133
Gao, A., Zhang, L., & Zhong, D. (2023). Chemotherapy-induced thrombocytopenia: Literature review. Discover. Oncology, 14(10): 1-14. https://doi.org/10.1007/s12672-023-00616-3
Hu, J., Tang, L., Cheng, Y., Liu, A., & Huang, L. (2022). Risk analysis of severe thrombocytopenia in nasopharyngeal carcinoma during concurrent radio-chemotherapy. Frontiers in oncology, 11 (754624): 1-10. https://doi.org/10.3389/fonc.2021.754624
Jinna, S., & Khandhar, P. B. (2023). Thrombocytopenia. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. Updated July 4, 2023. Available from https://www.ncbi.nlm.nih.gov/books/NBK542208/
Kumar, S., Mahdi, H., Bryant, C., Shah, J. P., Garg, G., & Munkarah, A. (2010). Clinical trials and progress with paclitaxel in ovarian cancer. International Journal of Women's Health, 2: 411–427. https://doi.org/10.2147/IJWH.S7012
Rallis, K. S., Lai Yau, T. H., & Sideris, M. (2021). Chemoradiotherapy in cancer treatment: Rationale and clinical applications. Anticancer Research, 41(1): 1–7. https://doi.org/10.21873/anticanres.14746
Reffai, A., Mesmoudi, M., Derkaoui, T., Ghailani Nourouti, N., Barakat, A., Sellal, N., Mallick, P., & Bennani Mechita, M. (2021). Epidemiological profile and clinicopathological, therapeutic, and prognostic characteristics of nasopharyngeal carcinoma in Northern Morocco. Cancer Control, 28: 1-12. https://doi.org/10.1177/10732748211050587
Romdhoni, A. C., Alkaff, F. F., Kahdina, M., et al. (2020). Radiotherapy effect on complete blood count parameter in patients with nasopharyngeal carcinoma. International Journal of Nasopharyngeal Carcinoma, 2(2): 7-9. https://repository.unair.ac.id/124114/1/10.%20Artikel.pdf
Shah, A. B., & Nagalli, S. (2022). Nasopharyngeal carcinoma. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. Updated October 1, 2022. Available from https://www.ncbi.nlm.nih.gov/books/NBK554588/
Shah, J., Patel, S., Singh, B., & Wong, R. (2020). Jatin Shah’s head and neck surgery and oncology (5th ed.). China: Elsevier.
Shao, L., Luo, Y., & Zhou, D. (2014). Hematopoietic stem cell injury induced by ionizing radiation. Antioxidants & Redox Signalling, 20(9): 1447–1462. https://doi.org/10.1089/ars.2013.5635
Sharif, S. E. T., Zawawi, N., Yajid, A. I., Md Shukri, N., & Mohamad, I. (2020). Pathology classification of nasopharyngeal carcinoma. An Evidence-Based Approach to the Management of Nasopharyngeal Cancer: 73-92. https://doi.org/10.1016/B978-0-12-814403-9.00005-7
Sinha, S., Winters, R., & Gajra, A. (2024). Nasopharyngeal cancer. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. Updated February 3, 2024. Available from https://www.ncbi.nlm.nih.gov/books/NBK459256/
Stan, D.J, Niculet, E., Lungu, M., Onisor, C., Rebegea, L., Vesa, D., Bezman, L., Bujoreanu, F. C., Sarbu, M. I., Mihailov, R., Fotea, S., & Tatu, A. L. (2022). Nasopharyngeal carcinoma: A new synthesis of literature data (Review). Experimental and Therapeutic Medicine, 23(136): 1-7. https://doi.org/10.3892/etm.2021.11059
Susetiyo, K. A., Kusumastuti, E. H., Yusuf, M., & Falerina, R. (2022). Clinicopathological profile of nasopharyngeal carcinoma in 2016-2019 at Dr. Soetomo General Hospital. Oto Rhino Laryngologica Indonesiana, 52(1): 7-12. https://doi.org/10.32637/orli.v52i1.474
Tan, C.K., Beh, S.P., Lee, R.-Y., Pei Jye, V., Damoderam, S., Mohd Naseri, N.I., Nagaswara, U., Yeo, G.G. (2018). Gender differences in risk of developing nasopharyngeal cancer (NPC) in one of the highest NPC ethnic groups in the world. Annals of Oncology, 29 (ix9: 1. https://doi.org/10.1093/annonc/mdy438.016
WHO (2020). Age-standardised (World) incidence rates, nasopharynx, males, all ages in Indonesia. World Health Organisation. https://gco.iarc.who.int/today/en/fact-sheets-populations/360/indonesia . Accessed on 28 February 2023
Widiastuti. (2019). Karsinoma nasofaring: Kadar Bcl-2, CD44 dan VEGF (1st ed.). Surakarta: UNS Press.
Wu, L., Li, C., & Pan, L. (2018). Nasopharyngeal carcinoma: A review of current updates. Experimental and Therapeutic Medicine, 15(4): 3687–3692. https://doi.org/10.3892/etm.2018.5878
Yao, J. J., Lin, L., Gao, T. S., Zhang, W. J., Lawrence, W. R., Ma, J., & Sun, Y. (2021). Development and validation of web-based nomograms to precisely predict survival outcomes of non-metastatic nasopharyngeal carcinoma in an endemic area. Cancer Research and Treatment, 53(3): 657–670. https://doi.org/10.4143/crt.2020.899
Yu, H., Yin, X., Mao, Y., Chen, M., Tang, Q., & Yan, S. (2022). The global burden of nasopharyngeal carcinoma from 2009 to 2019: An observational study based on the Global Burden of Disease Study 2019. European Archives of Oto-Rhino-Laryngology: 279(3): 1519–1533. https://doi.org/10.1007/s00405-021-06922-2
Zulkarnain, I., Surarso, B., & Purnami, N. (2017). Penurunan hemoglobin, neutrofil, dan trombosit pascakemoterapi cisplatin-paclitaxel pada penderita tumor ganas kepala dan leher. Jurnal THT-KL, 10, 1-10.




